Prelude Therapeutics
PRLD
#8532
Rank
C$0.37 B
Marketcap
C$4.63
Share price
-0.77%
Change (1 day)
96.71%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): C-$1.30

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.35. In 2025 the company made an earnings per share (EPS) of C-$1.85 an increase over its 2024 EPS that were of C-$2.41.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.30-29.76%
2025C-$1.85-23.21%
2024C-$2.41-16.83%
2023C-$2.90-17.21%
2022C-$3.500.41%
2021C-$3.48-46.71%
2020C-$6.54435.92%
2019C-$1.2286.09%
2018C-$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA